
GENFIT: Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with ...

Poster presentations will include new analysis of efficacy against drug resistant S. aureus in ...

BERKELEY, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), today announced ...
Click to continue to site. Closing